Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David Li Zeng is active.

Publication


Featured researches published by David Li Zeng.


International Journal of Pharmaceutics | 2012

Application of maximum bubble pressure surface tensiometer to study protein–surfactant interactions

Nitin Dixit; David Li Zeng; Devendra S. Kalonia

Binding of a surfactant to proteins can affect their physicochemical stability and solubility in a formulation. The extent of the effect depends on the binding stoichiometry. In this study, we have utilized the technique of maximum bubble pressure surface tensiometry to characterize the binding between human serum albumin (HSA) and surfactants (sodium dodecyl sulfate (SDS) and polysorbate 80) by dynamic surface tension measurements. Results show that two classes of binding sites are present in HSA for SDS, 5 primary binding sites with high binding affinity (K(a)=5.38×10(5) M(-1)) and 12 secondary binding sites with low affinity (K(a)=6.7×10(4) M(-1)). The binding is high affinity and limited capacity due to both, ionic and hydrophobic interactions between HSA and SDS. For polysorbate 80, the binding does not follow the Scatchard plot, and is low affinity and high capacity, indicating that polysorbate 80 interacts with HSA through hydrophobic interactions. The results show that maximal bubble pressure surface tensiometry is a fast and convenient technique to determine the concentration of free and bound surfactants in the presence of proteins.


Journal of Pharmaceutical Sciences | 2007

Antibody Structure, Instability, and Formulation

Wei Wang; Satish K. Singh; David Li Zeng; Kevin R. King; Sandeep Nema


Biophysical Journal | 2007

Ultrasonic Storage Modulus as a Novel Parameter for Analyzing Protein-Protein Interactions in High Protein Concentration Solutions: Correlation with Static and Dynamic Light Scattering Measurements

Atul Saluja; Advait Badkar; David Li Zeng; Sandeep Nema; Devendra S. Kalonia


Pharmaceutical Research | 2006

Protein Structural Conformation and Not Second Virial Coefficient Relates to Long-Term Irreversible Aggregation of a Monoclonal Antibody and Ovalbumin in Solution

Harminder Bajaj; Vikas Sharma; Advait Badkar; David Li Zeng; Sandeep Nema; Devendra S. Kalonia


Journal of Pharmaceutical Sciences | 2007

Ultrasonic rheology of a monoclonal antibody (IgG2) solution: Implications for physical stability of proteins in high concentration formulations

Atul Saluja; Advait Badkar; David Li Zeng; Devendra S. Kalonia


Journal of Pharmaceutical Sciences | 2006

Application of high‐frequency rheology measurements for analyzing protein–protein interactions in high protein concentration solutions using a model monoclonal antibody (IgG2)

Atul Saluja; Advait Badkar; David Li Zeng; Sandeep Nema; Devendra S. Kalonia


Journal of Pharmaceutical and Biomedical Analysis | 2007

Evaluation of the iCE280 Analyzer as a potential high-throughput tool for formulation development

Ning Li; Kendall Kessler; Laura Bass; David Li Zeng


Archive | 2006

Anti-M-CSF Antibody Compositions

James A. Carroll; Tapan Kanti Das; Corey M. Allan; Sandeep Nema; David Li Zeng


Archive | 2006

Anti-madcam antibody compositions

Corey M. Allan; Tapan Kanti Das; Scott Steven Ganser; Sandeep Nema; Satish Kumar Singh; David Li Zeng


Archive | 2006

Composition comprenant un anticorps contre le facteur de simulation de colonies de macrophages (M-CSF) et un agent chélatant

James A. Carroll; Tapan Kanti Das; Corey M. Allan; Sandeep Nema; David Li Zeng

Collaboration


Dive into the David Li Zeng's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Atul Saluja

University of Connecticut

View shared research outputs
Top Co-Authors

Avatar

Harminder Bajaj

University of Connecticut

View shared research outputs
Researchain Logo
Decentralizing Knowledge